Deferred Tax Assets, Net of Valuation Allowance in USD of IGC Pharma, Inc. from Q1 2019 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
IGC Pharma, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and change rate from Q1 2019 to Q1 2025.
- IGC Pharma, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Mar 2025 was $0.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)